论文部分内容阅读
Lorcaserin was approved in June 2012 by the FDA for the treatment of obesity.1 Several methods for the synthesis of lorcaserin have been reported,but these methods are unsuitable for industrial-scale production due to several drawbacks such as complicated purification process,low overall yields(7.2%~11.6%)and the employment of environmentally-unfriendly reagents.